Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Julphar
Chubb
Teva
Farmers Insurance
Baxter
Merck
Fish and Richardson
Cantor Fitzgerald
Queensland Health

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,232,304

« Back to Dashboard

Summary for Patent: 6,232,304
Title: Inclusion complexes of aryl-heterocyclic salts
Abstract:Compositions of matter comprising a pharmaceutically acceptable salt of an aryl-heterocyclic compound, such as ziprasidone, in a cyclodextrin. Preferred cyclodextrins are SBECD and HPBCD. The composition can comprise a dry mixture, a dry inclusion complex or an aqueous solution. The salt/cyclodextrin inclusion complex preferably provides an amount of ziprasidone of at least 2.5 mgA/ml when the complex is dissolved in water at 40% w/v. A variety of ziprasidone salts are preferred, including the mesylate, esylate, besylate, tartrate, napsylate, and tosylate.
Inventor(s): Kim; Yesook (Branford, CT), Johnson; Kevin C. (Niantic, CT), Shanker; Ravi M. (Groton, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/147,239
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation;

Drugs Protected by US Patent 6,232,304

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,232,304

PCT Information
PCT FiledApril 01, 1997PCT Application Number:PCT/IB97/00321
PCT Publication Date:November 13, 1997PCT Publication Number: WO97/41896

International Patents Family Members for US Patent 6,232,304

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan 514529 ➤ Try a Free Trial
Turkey 9802231 ➤ Try a Free Trial
Tunisia SN97075 ➤ Try a Free Trial
Slovakia 282032 ➤ Try a Free Trial
Slovakia 150498 ➤ Try a Free Trial
Slovenia 0900088 ➤ Try a Free Trial
Serbia 49532 ➤ Try a Free Trial
Yugoslavia 17297 ➤ Try a Free Trial
Portugal 900088 ➤ Try a Free Trial
Poland 189324 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Cipla
US Army
Julphar
McKesson
AstraZeneca
Colorcon
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot